Related references
Note: Only part of the references are listed.Studies on the reversible enzyme reaction of rabbit muscle glycogen phosphorylase b using isothermal titration calorimetry
Karmen Szabo et al.
CARBOHYDRATE RESEARCH (2019)
Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention
Sin Yee Tan et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus
Ramandeep Kaur et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Nanomolar Inhibitors of Glycogen Phosphorylase Based on β-D-Glucosaminyl Heterocycles: A Combined Synthetic, Enzyme Kinetic, and Protein Crystallography Study
Eva Bokor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
Arun Chaudhury et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Novel Liver-targeted conjugates of Glycogen Phosphorylase Inhibitor PSN-357 for the Treatment of Diabetes: Design, Synthesis, Pharmacokinetic and Pharmacological Evaluations
Liying Zhang et al.
SCIENTIFIC REPORTS (2017)
Multiple pharmacological targets, cytotoxicity, and phytochemical profile of Aphloia theiformis (Vahl.) Benn
Marie Carene Nancy Picot et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Glycogen phosphorylase inhibitors: a patent review (2013-2015)
Marion Donnier-Marechal et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Amy K. Rines et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Regulation of glucose metabolism from a liver-centric perspective
Hye-Sook Han et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b
Efthimios Kyriakis et al.
FEBS LETTERS (2015)
Role of glycogen phosphorylase in liver glycogen metabolism
Loranne Agius
MOLECULAR ASPECTS OF MEDICINE (2015)
Type 2 diabetes mellitus
Ralph A. DeFronzo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Natural products and their derivatives as inhibitors of glycogen phosphorylase: potential treatment for type 2 diabetes
Joseph M. Hayes et al.
PHYTOCHEMISTRY REVIEWS (2014)
Glycogen phosphorylase inhibitors: a patent review (2008-2012)
Nicolas Gaboriaud-Kolar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase
Atsushi Kato et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme
S. Freeman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Glycogen phosphorylase inhibitors
Brad R. Henke et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Glycogen phosphorylase, the product of the glgP gene, catalyzes glycogen breakdown by removing glucose units from the nonreducing ends in Escherichia coli
Nora Alonso-Casajus et al.
JOURNAL OF BACTERIOLOGY (2006)
Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature
DJ Baker et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Natural flavonoids are potent inhibitors of glycogen phosphorylase
S Jakobs et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Kinetic and substrate binding analysis of phosphorylase b via electrospray ionization mass spectrometry:: a model for chemical proteomics of sugar phosphorylases
CJ Zea et al.
ANALYTICAL BIOCHEMISTRY (2004)
The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors
B Andersen et al.
BIOCHEMICAL JOURNAL (2002)
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site
NG Oikonomakos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)